| Code | 93207 | ||||||||||
| MA number | 64/0208/04-S | ||||||||||
| Product Form: | ung oph 1x3,5 g (tuba Al) | ||||||||||
| MA Status: | D - Marketing Authorisation valid for an unlimited period | ||||||||||
| Type of procedure: | National | ||||||||||
| MAH, country: | Novartis Slovakia s.r.o., Slovakia | ||||||||||
| Therapeutic Class: | 64 - OPHTHALMOLOGICA | ||||||||||
| ATC: |
|
||||||||||
| Shelf life: | 36 | ||||||||||
| Container: | tube Al | ||||||||||
| Route of admin.: | Ocular use |
| Prescription Status: | Medicinal product subject to medical prescription. |
| Legal basis: | Article 8(3) application - known active substance |
| MA issued: | 30.04.2004 |
| Pediatric indication: | Yes |
| Pediatric posology: | Yes |
| SPC: |
SPC_Tobrex_ung_oph_10.2022.pdf
|
| PIL: |
PIL_TOBREX, ung oph_02/2025.pdf
|
| Safety feature | Yes |
| Data update: | 16.05.2018 |
